Skip to main content

 9OBE | pdb_00009obe

Crystal structure of human Argonaute2 in complex with a fully modified siRNA with a 5'-phenylpropyl phosphate


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 
    0.252 (Depositor), 0.254 (DCC) 
  • R-Value Work: 
    0.206 (Depositor), 0.206 (DCC) 
  • R-Value Observed: 
    0.209 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9OBE

This is version 1.2 of the entry. See complete history. 

Literature

Programmable Recognition of Organyl 5'-Phosphates by Human Argonaute-2.

Carrigan-Broda, T., Gebert, L.F.R., Hildebrand, S., Yamada, N., Luu, E., Caiazzi, J., McHugh, N., Echeverria, D., Wagh, A., Watts, J.K., Khvorova, A., MacRae, I.J., Yamada, K.

(2026) J Am Chem Soc 148: 38608-38618

  • DOI: https://doi.org/10.1021/jacs.6c03647
  • Primary Citation Related Structures: 
    36CK, 9OBD, 9OBE

  • PubMed Abstract: 

    To effectuate RNA interference (RNAi), Argonaute (AGO) proteins recognize and load RNA guide strands by their requisite 5'-phosphate (5'-P). However, the structural features that govern AGO2 tolerance for chemically modified 5'-P architectures remain poorly defined, despite their importance for small interfering RNA (siRNA) drug design. Moreover, degradative enzymes also recognize 5'-P, yet few stereoelectronic features are known to differentiate AGO2 recognition from competing degradation pathways. Here, we show that AGO2 accommodates a substantially broader range of 5'-P derivatives than previously recognized, and that select 5'-P mimics can exploit novel interactions with the protein to reinforce guide anchoring. Through systematic diversification of 35 organic substituents, we interrogated structural determinants of guide anchoring and enzymatic susceptibility. Our analysis identified previously uncharacterized 5'-P mimics, including methyl and phenylpropargyl 5'-phosphates (5'-PO-Me, 5'-PO-PhPrp), phenylpropargyl 5'-phosphorothioate (5'-PS-PhPrp), and 5'-mesylphosphoramidate (5'-MsPA), that preserve efficient AGO2 loading in cells while inhibiting phosphatase-mediated degradation. We further found that 5'-exonuclease susceptibility depends strongly on canonical 5' phosphate chemistry rather than steric accessibility. Structural analysis of a 5'-PO-PhPrp guide:AGO2 complex shows that the phenylpropargyl substituent engages a π-stacking network within a cluster of aromatic side chains (Y529/F811/Y815), while extended 5'-P substituents are accommodated through rotation of the 5'-P and coordinated rearrangement of water molecules within the 5'-P binding pocket. Collectively, these findings reveal the structural basis for plasticity of guide anchoring in AGO2 and establish chemically programmable 5'-end interactions as a general strategy for modulating oligonucleotide stability and activity.


  • Organizational Affiliation: 
    • RNA Therapeutics Institute, UMass Chan Medical School , 368 Plantation Street, Worcester, Massachusetts01605, United States.

Macromolecule Content 

  • Total Structure Weight: 104.78 kDa 
  • Atom Count: 6,875 
  • Modeled Residue Count: 814 
  • Deposited Residue Count: 880 
  • Unique protein chains: 1
  • Unique nucleic acid chains: 1

Macromolecules


Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Protein argonaute-2859Homo sapiensMutation(s): 0 
Gene Names: AGO2, EIF2C2
EC: 3.1.26
UniProt & NIH Common Fund Data Resources
Find proteins for Q9UKV8 (Homo sapiens)
Explore Q9UKV8 
Go to UniProtKB:  Q9UKV8
GTEx:  ENSG00000123908 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ9UKV8
Sequence Annotations
Expand
Reference Sequence
Find similar nucleic acids by:  Sequence
Entity ID: 2
MoleculeChains LengthOrganismImage
fully modified siRNA with a 5' phenylpropyl phosphate21synthetic construct
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free:  0.252 (Depositor), 0.254 (DCC) 
  • R-Value Work:  0.206 (Depositor), 0.206 (DCC) 
  • R-Value Observed: 0.209 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 63.116α = 90
b = 108.236β = 107.586
c = 68.529γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
ISOLDEmodel building
Cootmodel building
DIALSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesR35GM127090

Revision History  (Full details and data files)

  • Version 1.0: 2026-04-29
    Type: Initial release
  • Version 1.1: 2026-10-28
    Changes: Data collection
  • Version 1.2: 2026-11-11
    Changes: Database references